nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2C19—Rosuvastatin—atherosclerosis	0.0794	0.112	CbGbCtD
Arformoterol—CYP2C19—Simvastatin—atherosclerosis	0.0739	0.104	CbGbCtD
Arformoterol—CYP2C19—Lovastatin—atherosclerosis	0.0723	0.102	CbGbCtD
Arformoterol—CYP2D6—Niacin—atherosclerosis	0.071	0.1	CbGbCtD
Arformoterol—CYP2C9—Rosuvastatin—atherosclerosis	0.0661	0.093	CbGbCtD
Arformoterol—CYP2C9—Simvastatin—atherosclerosis	0.0614	0.0865	CbGbCtD
Arformoterol—CYP2C9—Lovastatin—atherosclerosis	0.0601	0.0846	CbGbCtD
Arformoterol—CYP2C9—Pravastatin—atherosclerosis	0.0601	0.0846	CbGbCtD
Arformoterol—CYP2D6—Simvastatin—atherosclerosis	0.0562	0.0791	CbGbCtD
Arformoterol—CYP2D6—Lovastatin—atherosclerosis	0.0549	0.0774	CbGbCtD
Arformoterol—CYP2D6—Pravastatin—atherosclerosis	0.0549	0.0774	CbGbCtD
Arformoterol—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000954	0.00396	CcSEcCtD
Arformoterol—Urinary tract infection—Lovastatin—atherosclerosis	0.000951	0.00395	CcSEcCtD
Arformoterol—Influenza—Niacin—atherosclerosis	0.000943	0.00391	CcSEcCtD
Arformoterol—Influenza—Pravastatin—atherosclerosis	0.000928	0.00385	CcSEcCtD
Arformoterol—Arrhythmia—Rosuvastatin—atherosclerosis	0.000926	0.00384	CcSEcCtD
Arformoterol—Angina pectoris—Niacin—atherosclerosis	0.000918	0.00381	CcSEcCtD
Arformoterol—Sinusitis—Lovastatin—atherosclerosis	0.000918	0.00381	CcSEcCtD
Arformoterol—Mental disorder—Rosuvastatin—atherosclerosis	0.000908	0.00377	CcSEcCtD
Arformoterol—Bronchitis—Niacin—atherosclerosis	0.000907	0.00376	CcSEcCtD
Arformoterol—Angina pectoris—Pravastatin—atherosclerosis	0.000904	0.00375	CcSEcCtD
Arformoterol—Sinusitis—Ezetimibe—atherosclerosis	0.000901	0.00374	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000863	0.00358	CcSEcCtD
Arformoterol—Sinusitis—Simvastatin—atherosclerosis	0.000859	0.00356	CcSEcCtD
Arformoterol—Pharyngitis—Ezetimibe—atherosclerosis	0.000855	0.00355	CcSEcCtD
Arformoterol—Oedema peripheral—Ezetimibe—atherosclerosis	0.000849	0.00352	CcSEcCtD
Arformoterol—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000847	0.00351	CcSEcCtD
Arformoterol—Angioedema—Rosuvastatin—atherosclerosis	0.000825	0.00342	CcSEcCtD
Arformoterol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000816	0.00339	CcSEcCtD
Arformoterol—Myocardial infarction—Pravastatin—atherosclerosis	0.000811	0.00337	CcSEcCtD
Arformoterol—Urinary tract infection—Pravastatin—atherosclerosis	0.000804	0.00334	CcSEcCtD
Arformoterol—Cough—Rosuvastatin—atherosclerosis	0.000787	0.00327	CcSEcCtD
Arformoterol—Immune system disorder—Ezetimibe—atherosclerosis	0.000778	0.00323	CcSEcCtD
Arformoterol—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000777	0.00322	CcSEcCtD
Arformoterol—Sinusitis—Pravastatin—atherosclerosis	0.000776	0.00322	CcSEcCtD
Arformoterol—Arthralgia—Rosuvastatin—atherosclerosis	0.000768	0.00319	CcSEcCtD
Arformoterol—Myalgia—Rosuvastatin—atherosclerosis	0.000768	0.00319	CcSEcCtD
Arformoterol—Rhinitis—Niacin—atherosclerosis	0.000756	0.00314	CcSEcCtD
Arformoterol—Mental disorder—Ezetimibe—atherosclerosis	0.000755	0.00313	CcSEcCtD
Arformoterol—Malnutrition—Ezetimibe—atherosclerosis	0.00075	0.00311	CcSEcCtD
Arformoterol—Dysgeusia—Lovastatin—atherosclerosis	0.000749	0.00311	CcSEcCtD
Arformoterol—Rhinitis—Pravastatin—atherosclerosis	0.000745	0.00309	CcSEcCtD
Arformoterol—Oedema peripheral—Niacin—atherosclerosis	0.000743	0.00308	CcSEcCtD
Arformoterol—Back pain—Lovastatin—atherosclerosis	0.00074	0.00307	CcSEcCtD
Arformoterol—Pharyngitis—Pravastatin—atherosclerosis	0.000737	0.00306	CcSEcCtD
Arformoterol—Muscle spasms—Lovastatin—atherosclerosis	0.000735	0.00305	CcSEcCtD
Arformoterol—Infection—Rosuvastatin—atherosclerosis	0.000732	0.00304	CcSEcCtD
Arformoterol—Visual impairment—Niacin—atherosclerosis	0.000727	0.00302	CcSEcCtD
Arformoterol—Back pain—Ezetimibe—atherosclerosis	0.000726	0.00301	CcSEcCtD
Arformoterol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000722	0.003	CcSEcCtD
Arformoterol—Muscle spasms—Ezetimibe—atherosclerosis	0.000721	0.00299	CcSEcCtD
Arformoterol—Mental disorder—Simvastatin—atherosclerosis	0.00072	0.00299	CcSEcCtD
Arformoterol—Tremor—Lovastatin—atherosclerosis	0.000716	0.00297	CcSEcCtD
Arformoterol—Visual impairment—Pravastatin—atherosclerosis	0.000716	0.00297	CcSEcCtD
Arformoterol—Ill-defined disorder—Lovastatin—atherosclerosis	0.00071	0.00294	CcSEcCtD
Arformoterol—Dysgeusia—Simvastatin—atherosclerosis	0.0007	0.00291	CcSEcCtD
Arformoterol—Angioedema—Lovastatin—atherosclerosis	0.000699	0.0029	CcSEcCtD
Arformoterol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000696	0.00289	CcSEcCtD
Arformoterol—Malaise—Lovastatin—atherosclerosis	0.00069	0.00286	CcSEcCtD
Arformoterol—Cardiac disorder—Pravastatin—atherosclerosis	0.000689	0.00286	CcSEcCtD
Arformoterol—Muscle spasms—Simvastatin—atherosclerosis	0.000688	0.00285	CcSEcCtD
Arformoterol—Angioedema—Ezetimibe—atherosclerosis	0.000685	0.00284	CcSEcCtD
Arformoterol—Malaise—Ezetimibe—atherosclerosis	0.000676	0.00281	CcSEcCtD
Arformoterol—Arrhythmia—Niacin—atherosclerosis	0.000674	0.0028	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000671	0.00278	CcSEcCtD
Arformoterol—Tremor—Simvastatin—atherosclerosis	0.00067	0.00278	CcSEcCtD
Arformoterol—Insomnia—Rosuvastatin—atherosclerosis	0.000666	0.00276	CcSEcCtD
Arformoterol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000664	0.00275	CcSEcCtD
Arformoterol—Arrhythmia—Pravastatin—atherosclerosis	0.000664	0.00275	CcSEcCtD
Arformoterol—Palpitations—Ezetimibe—atherosclerosis	0.000663	0.00275	CcSEcCtD
Arformoterol—Malnutrition—Niacin—atherosclerosis	0.000657	0.00273	CcSEcCtD
Arformoterol—Cough—Ezetimibe—atherosclerosis	0.000655	0.00272	CcSEcCtD
Arformoterol—Angioedema—Simvastatin—atherosclerosis	0.000654	0.00271	CcSEcCtD
Arformoterol—Arthralgia—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Arformoterol—Chest pain—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Arformoterol—Myalgia—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Arformoterol—Anxiety—Lovastatin—atherosclerosis	0.000649	0.00269	CcSEcCtD
Arformoterol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000648	0.00269	CcSEcCtD
Arformoterol—Hypertension—Ezetimibe—atherosclerosis	0.000648	0.00269	CcSEcCtD
Arformoterol—Malaise—Simvastatin—atherosclerosis	0.000645	0.00268	CcSEcCtD
Arformoterol—Tension—Niacin—atherosclerosis	0.000645	0.00267	CcSEcCtD
Arformoterol—Discomfort—Lovastatin—atherosclerosis	0.000643	0.00267	CcSEcCtD
Arformoterol—Arthralgia—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Arformoterol—Chest pain—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Arformoterol—Myalgia—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Arformoterol—Nervousness—Niacin—atherosclerosis	0.000638	0.00265	CcSEcCtD
Arformoterol—Dry mouth—Lovastatin—atherosclerosis	0.000637	0.00264	CcSEcCtD
Arformoterol—Tension—Pravastatin—atherosclerosis	0.000635	0.00263	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000634	0.00263	CcSEcCtD
Arformoterol—Dysgeusia—Pravastatin—atherosclerosis	0.000633	0.00263	CcSEcCtD
Arformoterol—Muscle spasms—Niacin—atherosclerosis	0.000631	0.00262	CcSEcCtD
Arformoterol—Discomfort—Ezetimibe—atherosclerosis	0.000631	0.00262	CcSEcCtD
Arformoterol—Pain—Rosuvastatin—atherosclerosis	0.00063	0.00261	CcSEcCtD
Arformoterol—Constipation—Rosuvastatin—atherosclerosis	0.00063	0.00261	CcSEcCtD
Arformoterol—Nervousness—Pravastatin—atherosclerosis	0.000628	0.00261	CcSEcCtD
Arformoterol—Dry mouth—Ezetimibe—atherosclerosis	0.000625	0.00259	CcSEcCtD
Arformoterol—Anaphylactic shock—Lovastatin—atherosclerosis	0.000624	0.00259	CcSEcCtD
Arformoterol—Muscle spasms—Pravastatin—atherosclerosis	0.000622	0.00258	CcSEcCtD
Arformoterol—Infection—Lovastatin—atherosclerosis	0.00062	0.00257	CcSEcCtD
Arformoterol—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000612	0.00254	CcSEcCtD
Arformoterol—Chest pain—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Arformoterol—Myalgia—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Arformoterol—Arthralgia—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Arformoterol—Infection—Ezetimibe—atherosclerosis	0.000608	0.00252	CcSEcCtD
Arformoterol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000607	0.00252	CcSEcCtD
Arformoterol—Anxiety—Simvastatin—atherosclerosis	0.000607	0.00252	CcSEcCtD
Arformoterol—Tremor—Pravastatin—atherosclerosis	0.000606	0.00251	CcSEcCtD
Arformoterol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000602	0.0025	CcSEcCtD
Arformoterol—Discomfort—Simvastatin—atherosclerosis	0.000602	0.0025	CcSEcCtD
Arformoterol—Nervous system disorder—Ezetimibe—atherosclerosis	0.0006	0.00249	CcSEcCtD
Arformoterol—Angioedema—Niacin—atherosclerosis	0.0006	0.00249	CcSEcCtD
Arformoterol—Ill-defined disorder—Pravastatin—atherosclerosis	0.0006	0.00249	CcSEcCtD
Arformoterol—Skin disorder—Ezetimibe—atherosclerosis	0.000595	0.00247	CcSEcCtD
Arformoterol—Angioedema—Pravastatin—atherosclerosis	0.000591	0.00245	CcSEcCtD
Arformoterol—Urticaria—Rosuvastatin—atherosclerosis	0.000585	0.00243	CcSEcCtD
Arformoterol—Oedema—Simvastatin—atherosclerosis	0.000584	0.00242	CcSEcCtD
Arformoterol—Anaphylactic shock—Simvastatin—atherosclerosis	0.000584	0.00242	CcSEcCtD
Arformoterol—Malaise—Pravastatin—atherosclerosis	0.000583	0.00242	CcSEcCtD
Arformoterol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000582	0.00242	CcSEcCtD
Arformoterol—Palpitations—Niacin—atherosclerosis	0.00058	0.00241	CcSEcCtD
Arformoterol—Infection—Simvastatin—atherosclerosis	0.00058	0.00241	CcSEcCtD
Arformoterol—Cough—Niacin—atherosclerosis	0.000573	0.00238	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000569	0.00236	CcSEcCtD
Arformoterol—Insomnia—Lovastatin—atherosclerosis	0.000565	0.00234	CcSEcCtD
Arformoterol—Cough—Pravastatin—atherosclerosis	0.000564	0.00234	CcSEcCtD
Arformoterol—Arthralgia—Niacin—atherosclerosis	0.000559	0.00232	CcSEcCtD
Arformoterol—Myalgia—Niacin—atherosclerosis	0.000559	0.00232	CcSEcCtD
Arformoterol—Hypertension—Pravastatin—atherosclerosis	0.000558	0.00232	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000558	0.00231	CcSEcCtD
Arformoterol—Dyspnoea—Lovastatin—atherosclerosis	0.000556	0.00231	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000555	0.0023	CcSEcCtD
Arformoterol—Insomnia—Ezetimibe—atherosclerosis	0.000554	0.0023	CcSEcCtD
Arformoterol—Arthralgia—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Arformoterol—Myalgia—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Arformoterol—Chest pain—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Arformoterol—Dyspepsia—Lovastatin—atherosclerosis	0.000549	0.00228	CcSEcCtD
Arformoterol—Anxiety—Pravastatin—atherosclerosis	0.000549	0.00228	CcSEcCtD
Arformoterol—Dry mouth—Niacin—atherosclerosis	0.000547	0.00227	CcSEcCtD
Arformoterol—Dyspnoea—Ezetimibe—atherosclerosis	0.000546	0.00226	CcSEcCtD
Arformoterol—Discomfort—Pravastatin—atherosclerosis	0.000544	0.00226	CcSEcCtD
Arformoterol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000543	0.00225	CcSEcCtD
Arformoterol—Dyspepsia—Ezetimibe—atherosclerosis	0.000539	0.00224	CcSEcCtD
Arformoterol—Fatigue—Lovastatin—atherosclerosis	0.000538	0.00223	CcSEcCtD
Arformoterol—Oedema—Niacin—atherosclerosis	0.000536	0.00222	CcSEcCtD
Arformoterol—Anaphylactic shock—Niacin—atherosclerosis	0.000536	0.00222	CcSEcCtD
Arformoterol—Pain—Lovastatin—atherosclerosis	0.000534	0.00221	CcSEcCtD
Arformoterol—Constipation—Lovastatin—atherosclerosis	0.000534	0.00221	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000532	0.00221	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000529	0.00219	CcSEcCtD
Arformoterol—Asthenia—Rosuvastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Arformoterol—Insomnia—Simvastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Arformoterol—Oedema—Pravastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Arformoterol—Anaphylactic shock—Pravastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Arformoterol—Fatigue—Ezetimibe—atherosclerosis	0.000528	0.00219	CcSEcCtD
Arformoterol—Infection—Pravastatin—atherosclerosis	0.000524	0.00218	CcSEcCtD
Arformoterol—Constipation—Ezetimibe—atherosclerosis	0.000523	0.00217	CcSEcCtD
Arformoterol—Pain—Ezetimibe—atherosclerosis	0.000523	0.00217	CcSEcCtD
Arformoterol—Tachycardia—Niacin—atherosclerosis	0.000523	0.00217	CcSEcCtD
Arformoterol—Pruritus—Rosuvastatin—atherosclerosis	0.000521	0.00216	CcSEcCtD
Arformoterol—Skin disorder—Niacin—atherosclerosis	0.000521	0.00216	CcSEcCtD
Arformoterol—Dyspnoea—Simvastatin—atherosclerosis	0.00052	0.00216	CcSEcCtD
Arformoterol—Feeling abnormal—Lovastatin—atherosclerosis	0.000514	0.00213	CcSEcCtD
Arformoterol—Dyspepsia—Simvastatin—atherosclerosis	0.000514	0.00213	CcSEcCtD
Arformoterol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00051	0.00212	CcSEcCtD
Arformoterol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000504	0.00209	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000504	0.00209	CcSEcCtD
Arformoterol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000504	0.00209	CcSEcCtD
Arformoterol—Fatigue—Simvastatin—atherosclerosis	0.000503	0.00209	CcSEcCtD
Arformoterol—Hypotension—Niacin—atherosclerosis	0.000501	0.00208	CcSEcCtD
Arformoterol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000501	0.00208	CcSEcCtD
Arformoterol—Pain—Simvastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Arformoterol—Constipation—Simvastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Arformoterol—Urticaria—Lovastatin—atherosclerosis	0.000496	0.00206	CcSEcCtD
Arformoterol—Abdominal pain—Lovastatin—atherosclerosis	0.000493	0.00205	CcSEcCtD
Arformoterol—Body temperature increased—Lovastatin—atherosclerosis	0.000493	0.00205	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000488	0.00203	CcSEcCtD
Arformoterol—Dizziness—Rosuvastatin—atherosclerosis	0.000487	0.00202	CcSEcCtD
Arformoterol—Urticaria—Ezetimibe—atherosclerosis	0.000486	0.00202	CcSEcCtD
Arformoterol—Insomnia—Niacin—atherosclerosis	0.000485	0.00201	CcSEcCtD
Arformoterol—Abdominal pain—Ezetimibe—atherosclerosis	0.000484	0.00201	CcSEcCtD
Arformoterol—Body temperature increased—Ezetimibe—atherosclerosis	0.000484	0.00201	CcSEcCtD
Arformoterol—Feeling abnormal—Simvastatin—atherosclerosis	0.000481	0.002	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000481	0.002	CcSEcCtD
Arformoterol—Dyspnoea—Niacin—atherosclerosis	0.000478	0.00198	CcSEcCtD
Arformoterol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Arformoterol—Insomnia—Pravastatin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Arformoterol—Somnolence—Niacin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Arformoterol—Dyspepsia—Niacin—atherosclerosis	0.000472	0.00196	CcSEcCtD
Arformoterol—Dyspnoea—Pravastatin—atherosclerosis	0.000471	0.00195	CcSEcCtD
Arformoterol—Dyspepsia—Pravastatin—atherosclerosis	0.000465	0.00193	CcSEcCtD
Arformoterol—Rash—Rosuvastatin—atherosclerosis	0.000464	0.00193	CcSEcCtD
Arformoterol—Dermatitis—Rosuvastatin—atherosclerosis	0.000464	0.00193	CcSEcCtD
Arformoterol—Urticaria—Simvastatin—atherosclerosis	0.000464	0.00192	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000463	0.00192	CcSEcCtD
Arformoterol—Abdominal pain—Simvastatin—atherosclerosis	0.000462	0.00192	CcSEcCtD
Arformoterol—Body temperature increased—Simvastatin—atherosclerosis	0.000462	0.00192	CcSEcCtD
Arformoterol—Headache—Rosuvastatin—atherosclerosis	0.000461	0.00191	CcSEcCtD
Arformoterol—Hypersensitivity—Lovastatin—atherosclerosis	0.00046	0.00191	CcSEcCtD
Arformoterol—Pain—Niacin—atherosclerosis	0.000458	0.0019	CcSEcCtD
Arformoterol—Fatigue—Pravastatin—atherosclerosis	0.000455	0.00189	CcSEcCtD
Arformoterol—Pain—Pravastatin—atherosclerosis	0.000451	0.00187	CcSEcCtD
Arformoterol—Constipation—Pravastatin—atherosclerosis	0.000451	0.00187	CcSEcCtD
Arformoterol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000451	0.00187	CcSEcCtD
Arformoterol—Asthenia—Lovastatin—atherosclerosis	0.000448	0.00186	CcSEcCtD
Arformoterol—Pruritus—Lovastatin—atherosclerosis	0.000442	0.00183	CcSEcCtD
Arformoterol—Asthenia—Ezetimibe—atherosclerosis	0.000439	0.00182	CcSEcCtD
Arformoterol—Gastrointestinal pain—Niacin—atherosclerosis	0.000438	0.00182	CcSEcCtD
Arformoterol—Nausea—Rosuvastatin—atherosclerosis	0.000437	0.00182	CcSEcCtD
Arformoterol—Feeling abnormal—Pravastatin—atherosclerosis	0.000435	0.0018	CcSEcCtD
Arformoterol—Pruritus—Ezetimibe—atherosclerosis	0.000433	0.0018	CcSEcCtD
Arformoterol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000432	0.00179	CcSEcCtD
Arformoterol—Hypersensitivity—Simvastatin—atherosclerosis	0.00043	0.00178	CcSEcCtD
Arformoterol—Diarrhoea—Lovastatin—atherosclerosis	0.000427	0.00177	CcSEcCtD
Arformoterol—Urticaria—Niacin—atherosclerosis	0.000426	0.00177	CcSEcCtD
Arformoterol—Abdominal pain—Niacin—atherosclerosis	0.000424	0.00176	CcSEcCtD
Arformoterol—Body temperature increased—Niacin—atherosclerosis	0.000424	0.00176	CcSEcCtD
Arformoterol—Urticaria—Pravastatin—atherosclerosis	0.000419	0.00174	CcSEcCtD
Arformoterol—Asthenia—Simvastatin—atherosclerosis	0.000419	0.00174	CcSEcCtD
Arformoterol—Diarrhoea—Ezetimibe—atherosclerosis	0.000419	0.00174	CcSEcCtD
Arformoterol—Body temperature increased—Pravastatin—atherosclerosis	0.000417	0.00173	CcSEcCtD
Arformoterol—Abdominal pain—Pravastatin—atherosclerosis	0.000417	0.00173	CcSEcCtD
Arformoterol—Pruritus—Simvastatin—atherosclerosis	0.000413	0.00171	CcSEcCtD
Arformoterol—Dizziness—Lovastatin—atherosclerosis	0.000413	0.00171	CcSEcCtD
Arformoterol—Dizziness—Ezetimibe—atherosclerosis	0.000405	0.00168	CcSEcCtD
Arformoterol—Diarrhoea—Simvastatin—atherosclerosis	0.000399	0.00166	CcSEcCtD
Arformoterol—Vomiting—Lovastatin—atherosclerosis	0.000397	0.00165	CcSEcCtD
Arformoterol—Hypersensitivity—Niacin—atherosclerosis	0.000395	0.00164	CcSEcCtD
Arformoterol—Rash—Lovastatin—atherosclerosis	0.000394	0.00163	CcSEcCtD
Arformoterol—Dermatitis—Lovastatin—atherosclerosis	0.000393	0.00163	CcSEcCtD
Arformoterol—Headache—Lovastatin—atherosclerosis	0.000391	0.00162	CcSEcCtD
Arformoterol—Vomiting—Ezetimibe—atherosclerosis	0.000389	0.00162	CcSEcCtD
Arformoterol—Hypersensitivity—Pravastatin—atherosclerosis	0.000389	0.00161	CcSEcCtD
Arformoterol—Dizziness—Simvastatin—atherosclerosis	0.000386	0.0016	CcSEcCtD
Arformoterol—Rash—Ezetimibe—atherosclerosis	0.000386	0.0016	CcSEcCtD
Arformoterol—Dermatitis—Ezetimibe—atherosclerosis	0.000386	0.0016	CcSEcCtD
Arformoterol—Asthenia—Niacin—atherosclerosis	0.000385	0.0016	CcSEcCtD
Arformoterol—Headache—Ezetimibe—atherosclerosis	0.000384	0.00159	CcSEcCtD
Arformoterol—Pruritus—Niacin—atherosclerosis	0.000379	0.00157	CcSEcCtD
Arformoterol—Asthenia—Pravastatin—atherosclerosis	0.000379	0.00157	CcSEcCtD
Arformoterol—Pruritus—Pravastatin—atherosclerosis	0.000373	0.00155	CcSEcCtD
Arformoterol—Vomiting—Simvastatin—atherosclerosis	0.000371	0.00154	CcSEcCtD
Arformoterol—Nausea—Lovastatin—atherosclerosis	0.000371	0.00154	CcSEcCtD
Arformoterol—Rash—Simvastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Arformoterol—Dermatitis—Simvastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Arformoterol—Diarrhoea—Niacin—atherosclerosis	0.000367	0.00152	CcSEcCtD
Arformoterol—Headache—Simvastatin—atherosclerosis	0.000366	0.00152	CcSEcCtD
Arformoterol—Nausea—Ezetimibe—atherosclerosis	0.000364	0.00151	CcSEcCtD
Arformoterol—Diarrhoea—Pravastatin—atherosclerosis	0.000361	0.0015	CcSEcCtD
Arformoterol—Dizziness—Niacin—atherosclerosis	0.000354	0.00147	CcSEcCtD
Arformoterol—Dizziness—Pravastatin—atherosclerosis	0.000349	0.00145	CcSEcCtD
Arformoterol—Nausea—Simvastatin—atherosclerosis	0.000347	0.00144	CcSEcCtD
Arformoterol—Vomiting—Niacin—atherosclerosis	0.000341	0.00141	CcSEcCtD
Arformoterol—Rash—Niacin—atherosclerosis	0.000338	0.0014	CcSEcCtD
Arformoterol—Dermatitis—Niacin—atherosclerosis	0.000338	0.0014	CcSEcCtD
Arformoterol—Headache—Niacin—atherosclerosis	0.000336	0.00139	CcSEcCtD
Arformoterol—Vomiting—Pravastatin—atherosclerosis	0.000336	0.00139	CcSEcCtD
Arformoterol—Rash—Pravastatin—atherosclerosis	0.000333	0.00138	CcSEcCtD
Arformoterol—Dermatitis—Pravastatin—atherosclerosis	0.000332	0.00138	CcSEcCtD
Arformoterol—Headache—Pravastatin—atherosclerosis	0.000331	0.00137	CcSEcCtD
Arformoterol—Nausea—Niacin—atherosclerosis	0.000318	0.00132	CcSEcCtD
Arformoterol—Nausea—Pravastatin—atherosclerosis	0.000314	0.0013	CcSEcCtD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOA2—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.16e-05	0.000443	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.15e-05	0.000441	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.15e-05	0.000441	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.11e-05	0.000434	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.11e-05	0.000433	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ABCA1—atherosclerosis	2.1e-05	0.000432	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.09e-05	0.00043	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LPA—atherosclerosis	2.08e-05	0.000426	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.07e-05	0.000424	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.06e-05	0.000423	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.02e-05	0.000415	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—BGN—atherosclerosis	2.01e-05	0.000413	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.01e-05	0.000413	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX15—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOA2—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2e-05	0.00041	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOA5—atherosclerosis	1.99e-05	0.000409	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOA2—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	1.98e-05	0.000406	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.98e-05	0.000406	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.96e-05	0.000402	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.96e-05	0.000402	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.93e-05	0.000397	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	1.93e-05	0.000397	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	1.92e-05	0.000394	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000393	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LPA—atherosclerosis	1.91e-05	0.000392	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.89e-05	0.000389	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LPA—atherosclerosis	1.89e-05	0.000389	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	1.89e-05	0.000388	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	1.88e-05	0.000387	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	1.88e-05	0.000386	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.88e-05	0.000385	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.87e-05	0.000384	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PLG—atherosclerosis	1.87e-05	0.000384	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.85e-05	0.00038	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—BGN—atherosclerosis	1.85e-05	0.00038	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	1.84e-05	0.000378	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—BGN—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PLG—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOA5—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.82e-05	0.000374	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOA5—atherosclerosis	1.82e-05	0.000372	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.8e-05	0.00037	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.77e-05	0.000364	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.76e-05	0.000362	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.76e-05	0.000362	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.75e-05	0.000359	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.73e-05	0.000356	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOB—atherosclerosis	1.73e-05	0.000355	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.73e-05	0.000355	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.71e-05	0.00035	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.7e-05	0.00035	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.7e-05	0.000349	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.69e-05	0.000346	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.68e-05	0.000345	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.67e-05	0.000344	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.67e-05	0.000342	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000341	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.65e-05	0.00034	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—LPL—atherosclerosis	1.65e-05	0.000339	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.65e-05	0.000339	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000338	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.64e-05	0.000337	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000336	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LDLR—atherosclerosis	1.63e-05	0.000334	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.63e-05	0.000334	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.62e-05	0.000332	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.62e-05	0.000332	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GPX1—atherosclerosis	1.61e-05	0.000331	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.61e-05	0.000329	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.59e-05	0.000327	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CETP—atherosclerosis	1.59e-05	0.000327	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.58e-05	0.000324	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.58e-05	0.000324	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CD36—atherosclerosis	1.57e-05	0.000322	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.56e-05	0.00032	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.55e-05	0.000317	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.54e-05	0.000315	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.53e-05	0.000313	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.52e-05	0.000313	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.52e-05	0.000311	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.51e-05	0.000311	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.51e-05	0.000309	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.5e-05	0.000309	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000309	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.5e-05	0.000308	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.5e-05	0.000308	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.5e-05	0.000307	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOC3—atherosclerosis	1.49e-05	0.000307	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.49e-05	0.000306	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.49e-05	0.000305	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LDLR—atherosclerosis	1.49e-05	0.000305	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.48e-05	0.000304	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.46e-05	0.0003	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CETP—atherosclerosis	1.46e-05	0.0003	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARA—atherosclerosis	1.46e-05	0.000299	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.46e-05	0.000299	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CETP—atherosclerosis	1.45e-05	0.000298	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000295	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AGT—atherosclerosis	1.41e-05	0.00029	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.4e-05	0.000288	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.39e-05	0.000285	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAV1—atherosclerosis	1.37e-05	0.000281	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOA1—atherosclerosis	1.37e-05	0.000281	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.35e-05	0.000278	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.35e-05	0.000278	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.35e-05	0.000277	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.32e-05	0.000271	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.26e-05	0.00026	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.25e-05	0.000256	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.25e-05	0.000256	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.24e-05	0.000254	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.22e-05	0.000251	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARG—atherosclerosis	1.21e-05	0.000247	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.2e-05	0.000245	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.18e-05	0.000243	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—INS—atherosclerosis	1.18e-05	0.000243	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.18e-05	0.000242	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.17e-05	0.00024	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.17e-05	0.00024	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.14e-05	0.000235	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.13e-05	0.000232	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.12e-05	0.00023	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.11e-05	0.000228	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.11e-05	0.000227	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000226	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.09e-05	0.000225	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.09e-05	0.000224	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ALB—atherosclerosis	1.08e-05	0.000222	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.07e-05	0.00022	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOB—atherosclerosis	1.05e-05	0.000216	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.04e-05	0.000213	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—atherosclerosis	1.04e-05	0.000213	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.00021	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.02e-05	0.000209	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.01e-05	0.000208	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—LPL—atherosclerosis	1.01e-05	0.000207	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—atherosclerosis	1e-05	0.000206	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	9.92e-06	0.000204	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GPX1—atherosclerosis	9.82e-06	0.000202	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	9.71e-06	0.000199	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOB—atherosclerosis	9.7e-06	0.000199	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOB—atherosclerosis	9.61e-06	0.000197	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CD36—atherosclerosis	9.56e-06	0.000196	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—atherosclerosis	9.48e-06	0.000195	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.43e-06	0.000194	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTM1—atherosclerosis	9.35e-06	0.000192	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—LPL—atherosclerosis	9.26e-06	0.00019	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—LPL—atherosclerosis	9.18e-06	0.000188	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.06e-06	0.000186	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GPX1—atherosclerosis	9.03e-06	0.000185	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GPX1—atherosclerosis	8.95e-06	0.000184	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARA—atherosclerosis	8.89e-06	0.000182	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	8.8e-06	0.000181	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CD36—atherosclerosis	8.8e-06	0.000181	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CD36—atherosclerosis	8.72e-06	0.000179	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AGT—atherosclerosis	8.61e-06	0.000177	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	8.61e-06	0.000177	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	8.5e-06	0.000175	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—atherosclerosis	8.44e-06	0.000173	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	8.37e-06	0.000172	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAV1—atherosclerosis	8.36e-06	0.000172	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOA1—atherosclerosis	8.34e-06	0.000171	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.34e-06	0.000171	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	8.32e-06	0.000171	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.26e-06	0.00017	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	8.19e-06	0.000168	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARA—atherosclerosis	8.18e-06	0.000168	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARA—atherosclerosis	8.11e-06	0.000166	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	7.96e-06	0.000163	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AGT—atherosclerosis	7.92e-06	0.000163	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	7.88e-06	0.000162	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AGT—atherosclerosis	7.85e-06	0.000161	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.79e-06	0.00016	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—atherosclerosis	7.76e-06	0.000159	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	7.74e-06	0.000159	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	7.72e-06	0.000158	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	7.71e-06	0.000158	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—atherosclerosis	7.69e-06	0.000158	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAV1—atherosclerosis	7.69e-06	0.000158	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOA1—atherosclerosis	7.67e-06	0.000157	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAV1—atherosclerosis	7.62e-06	0.000156	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.61e-06	0.000156	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOA1—atherosclerosis	7.6e-06	0.000156	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	7.57e-06	0.000155	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	7.55e-06	0.000155	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARG—atherosclerosis	7.35e-06	0.000151	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—INS—atherosclerosis	7.21e-06	0.000148	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	7.15e-06	0.000147	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	7.08e-06	0.000145	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7e-06	0.000144	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.99e-06	0.000144	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.94e-06	0.000142	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.92e-06	0.000142	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	6.76e-06	0.000139	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARG—atherosclerosis	6.76e-06	0.000139	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARG—atherosclerosis	6.7e-06	0.000138	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—INS—atherosclerosis	6.63e-06	0.000136	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	6.62e-06	0.000136	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ALB—atherosclerosis	6.61e-06	0.000136	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—INS—atherosclerosis	6.57e-06	0.000135	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	6.56e-06	0.000135	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	6.42e-06	0.000132	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—atherosclerosis	6.32e-06	0.00013	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ALB—atherosclerosis	6.08e-06	0.000125	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ALB—atherosclerosis	6.03e-06	0.000124	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—atherosclerosis	5.81e-06	0.000119	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.78e-06	0.000119	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—atherosclerosis	5.76e-06	0.000118	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.32e-06	0.000109	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.27e-06	0.000108	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—atherosclerosis	4.94e-06	0.000101	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.84e-06	9.93e-05	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AKT1—atherosclerosis	4.77e-06	9.78e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	4.56e-06	9.36e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.46e-06	9.16e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AKT1—atherosclerosis	2.91e-06	5.96e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKT1—atherosclerosis	2.67e-06	5.48e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKT1—atherosclerosis	2.65e-06	5.44e-05	CbGpPWpGaD
